{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:44:31Z","timestamp":1792457071889,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,19]]},"DOI":"10.7759\/cureus.82579","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T12:49:31Z","timestamp":1745066971000},"source":"Crossref","is-referenced-by-count":16,"title":["Chronic Inflammation: A Multidisciplinary Analysis of Shared Pathways in Autoimmune, Infectious, and Degenerative Diseases"],"prefix":"10.7759","author":[{"given":"Ayadi","family":"Yacine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Zain Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal Bayen","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huda","family":"Qubayl Alanaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Saud Alrahili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad A","family":"Alkhdairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00316","article-title":"Inflammation-nature\u2019s way to efficiently respond to all types of challenges: implications for understanding and managing \u201cthe epidemic\u201d of chronic diseases","volume":"5","author":"Bennett JM","year":"2018","unstructured":"Bennett JM, Reeves G, Billman GE, Sturmberg JP. Inflammation-nature\u2019s way to efficiently respond to all types of challenges: implications for understanding and managing \u201cthe epidemic\u201d of chronic diseases. Front Med (Lausanne). 2018, 5:316. 10.3389\/fmed.2018.00316","journal-title":"Front Med (Lausanne)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24087288","article-title":"Immune-mediated neuropathies: pathophysiology and management","volume":"24","author":"Shastri A","year":"2023","unstructured":"Shastri A, Al Aiyan A, Kishore U, Farrugia ME. Immune-mediated neuropathies: pathophysiology and management. Int J Mol Sci. 2023, 24:10.3390\/ijms24087288","journal-title":"Int J Mol Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27086","article-title":"Metabolic syndrome and peripheral neuropathy","volume":"63","author":"Kazamel M","year":"2021","unstructured":"Kazamel M, Stino AM, Smith AG. Metabolic syndrome and peripheral neuropathy. Muscle Nerve. 2021, 63:285-93. 10.1002\/mus.27086","journal-title":"Muscle Nerve"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2018.1396876","article-title":"Chronic periodontitis, inflammatory cytokines, and interrelationship with other chronic diseases","volume":"130","author":"Cardoso EM","year":"2018","unstructured":"Cardoso EM, Reis C, Manzanares-C\u00e9spedes MC. Chronic periodontitis, inflammatory cytokines, and interrelationship with other chronic diseases. Postgrad Med. 2018, 130:98-104. 10.1080\/00325481.2018.1396876","journal-title":"Postgrad Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2018.02.013","article-title":"Rethinking IL-6 and CRP: why they are more than inflammatory biomarkers, and why it matters","volume":"70","author":"Del Giudice M","year":"2018","unstructured":"Del Giudice M, Gangestad SW. Rethinking IL-6 and CRP: why they are more than inflammatory biomarkers, and why it matters. Brain Behav Immun. 2018, 70:61-75. 10.1016\/j.bbi.2018.02.013","journal-title":"Brain Behav Immun"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.792","article-title":"Inflammation: treatment progress and limitations","volume":"102","author":"Cascorbi I","year":"2017","unstructured":"Cascorbi I. Inflammation: treatment progress and limitations. Clin Pharmacol Ther. 2017, 102:564-7. 10.1002\/cpt.792","journal-title":"Clin Pharmacol Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000001083","article-title":"Neural control of inflammation: implications for perioperative and critical care","volume":"124","author":"Steinberg BE","year":"2016","unstructured":"Steinberg BE, Sundman E, Terrando N, Eriksson LI, Olofsson PS. Neural control of inflammation: implications for perioperative and critical care. Anesthesiology. 2016, 124:1174-89. 10.1097\/ALN.0000000000001083","journal-title":"Anesthesiology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjmed-2021-000108","article-title":"Chronic pain and infection: mechanisms, causes, conditions, treatments, and controversies","volume":"1","author":"Cohen SP","year":"2022","unstructured":"Cohen SP, Wang EJ, Doshi TL, Vase L, Cawcutt KA, Tontisirin N. Chronic pain and infection: mechanisms, causes, conditions, treatments, and controversies. BMJ Med. 2022, 1:e000108. 10.1136\/bmjmed-2021-000108","journal-title":"BMJ Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232214222","article-title":"Triggers of Guillain-Barr\u00e9 syndrome: Campylobacter jejuni predominates","volume":"23","author":"Finsterer J","year":"2022","unstructured":"Finsterer J. Triggers of Guillain-Barr\u00e9 syndrome: Campylobacter jejuni predominates. Int J Mol Sci. 2022, 23:10.3390\/ijms232214222","journal-title":"Int J Mol Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005615","article-title":"Virus infections incite pain hypersensitivity by inducing indoleamine 2,3 dioxygenase","volume":"12","author":"Huang L","year":"2016","unstructured":"Huang L, Ou R, Rabelo de Souza G, et al.. Virus infections incite pain hypersensitivity by inducing indoleamine 2,3 dioxygenase. PLoS Pathog. 2016, 12:e1005615. 10.1371\/journal.ppat.1005615","journal-title":"PLoS Pathog"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnx057","article-title":"Detectable viral load may be associated with increased pain sensitivity in persons living with HIV: preliminary findings","volume":"18","author":"Goodin BR","year":"2017","unstructured":"Goodin BR, Owens MA, Yessick LR, et al.. Detectable viral load may be associated with increased pain sensitivity in persons living with HIV: preliminary findings. Pain Med. 2017, 18:2289-95. 10.1093\/pm\/pnx057","journal-title":"Pain Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.757302","article-title":"Cumulative roles for Epstein-Barr virus, human endogenous retroviruses, and human herpes virus-6 in driving an inflammatory cascade underlying MS pathogenesis","volume":"12","author":"Meier UC","year":"2021","unstructured":"Meier UC, Cipian RC, Karimi A, Ramasamy R, Middeldorp JM. Cumulative roles for Epstein-Barr virus, human endogenous retroviruses, and human herpes virus-6 in driving an inflammatory cascade underlying MS pathogenesis. Front Immunol. 2021, 12:757302. 10.3389\/fimmu.2021.757302","journal-title":"Front Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-021-01678-x","article-title":"Anti-viral and pro-inflammatory functions of Toll-like receptors during gamma-herpesvirus infections","volume":"18","author":"Gaglia MM","year":"2021","unstructured":"Gaglia MM. Anti-viral and pro-inflammatory functions of Toll-like receptors during gamma-herpesvirus infections. Virol J. 2021, 18:218. 10.1186\/s12985-021-01678-x","journal-title":"Virol J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.124.324674","article-title":"Clinical characteristics and mechanisms of acute myocarditis","volume":"135","author":"Heymans S","year":"2024","unstructured":"Heymans S, Van Linthout S, Kraus SM, Cooper LT, Ntusi NA. Clinical characteristics and mechanisms of acute myocarditis. Circ Res. 2024, 135:397-411. 10.1161\/CIRCRESAHA.124.324674","journal-title":"Circ Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3344\/kjp.23129","article-title":"Antimicrobial therapies for chronic pain (part 1): analgesic mechanisms","volume":"36","author":"Wang EJ","year":"2023","unstructured":"Wang EJ, Karri J, Tontisirin N, Cohen SP. Antimicrobial therapies for chronic pain (part 1): analgesic mechanisms. Korean J Pain. 2023, 36:281-98. 10.3344\/kjp.23129","journal-title":"Korean J Pain"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics9030091","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome: a comprehensive review","volume":"9","author":"Cortes Rivera M","year":"2019","unstructured":"Cortes Rivera M, Mastronardi C, Silva-Aldana CT, Arcos-Burgos M, Lidbury BA. Myalgic encephalomyelitis\/chronic fatigue syndrome: a comprehensive review. Diagnostics (Basel). 2019, 9:10.3390\/diagnostics9030091","journal-title":"Diagnostics (Basel)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1101\/2025.01.09.25320264","article-title":"Autoantibody-driven monocyte dysfunction in post-COVID syndrome with myalgic encephalomyelitis\/chronic fatigue syndrome","author":"Hackel A","year":"2025","unstructured":"Hackel A, Sotzny F, Mennenga E, et al.. Autoantibody-driven monocyte dysfunction in post-COVID syndrome with myalgic encephalomyelitis\/chronic fatigue syndrome. medRxiv. 2025, 10.1101\/2025.01.09.25320264","journal-title":"medRxiv"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s40200-021-00734-1","article-title":"Inflammatory biomarkers as a part of diagnosis in diabetic peripheral neuropathy","volume":"20","author":"M SL","year":"2021","unstructured":"M SL, O P. Inflammatory biomarkers as a part of diagnosis in diabetic peripheral neuropathy. J Diabetes Metab Disord. 2021, 20:869-82. 10.1007\/s40200-021-00734-1","journal-title":"J Diabetes Metab Disord"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2217\/nmt-2021-0015","article-title":"Evidence base for investigative and therapeutic modalities in chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy","volume":"12","author":"Goedee HS","year":"2022","unstructured":"Goedee HS, Rajabally YA. Evidence base for investigative and therapeutic modalities in chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy. Neurodegener Dis Manag. 2022, 12:35-47. 10.2217\/nmt-2021-0015","journal-title":"Neurodegener Dis Manag"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15815","article-title":"Chronic inflammatory neuropathies and their impact on activities and participation","volume":"30","author":"Wonink HA","year":"2023","unstructured":"Wonink HA, Kruithof WJ, Goedee HS, Beelen A. Chronic inflammatory neuropathies and their impact on activities and participation. Eur J Neurol. 2023, 30:1928-36. 10.1111\/ene.15815","journal-title":"Eur J Neurol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1042\/BST20190029","article-title":"Biomarkers of inflammation and the etiology of sepsis","volume":"48","author":"Grondman I","year":"2020","unstructured":"Grondman I, Pirvu A, Riza A, Ioana M, Netea MG. Biomarkers of inflammation and the etiology of sepsis. Biochem Soc Trans. 2020, 48:1-14. 10.1042\/BST20190029","journal-title":"Biochem Soc Trans"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2023.103116","article-title":"Heart rate variability as a marker and predictor of inflammation, nosocomial infection, and sepsis - a systematic review","volume":"249","author":"Adam J","year":"2023","unstructured":"Adam J, Rupprecht S, K\u00fcnstler EC, Hoyer D. Heart rate variability as a marker and predictor of inflammation, nosocomial infection, and sepsis - a systematic review. Auton Neurosci. 2023, 249:103116. 10.1016\/j.autneu.2023.103116","journal-title":"Auton Neurosci"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.resuscitation.2017.10.013","article-title":"Post-cardiac arrest syndrome: pathological processes, biomarkers and vasopressor support, and potential therapeutic targets","volume":"121","author":"Mentzelopoulos SD","year":"2017","unstructured":"Mentzelopoulos SD, Zakynthinos SG. Post-cardiac arrest syndrome: pathological processes, biomarkers and vasopressor support, and potential therapeutic targets. Resuscitation. 2017, 121:A12-4. 10.1016\/j.resuscitation.2017.10.013","journal-title":"Resuscitation"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cger.2022.07.004","article-title":"Brain networks, clinical manifestations, and neuroimaging of cognitive disorders: the role of computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), and other advanced neuroimaging tests","volume":"39","author":"Bonakdarpour B","year":"2023","unstructured":"Bonakdarpour B, Takarabe C. Brain networks, clinical manifestations, and neuroimaging of cognitive disorders: the role of computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), and other advanced neuroimaging tests. Clin Geriatr Med. 2023, 39:45-65. 10.1016\/j.cger.2022.07.004","journal-title":"Clin Geriatr Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.11.037","article-title":"New and old biomarkers for diagnosis and management of chronic hepatitis B virus infection","volume":"156","author":"Coffin CS","year":"2019","unstructured":"Coffin CS, Zhou K, Terrault NA. New and old biomarkers for diagnosis and management of chronic hepatitis B virus infection. Gastroenterology. 2019, 156:355-68.e3. 10.1053\/j.gastro.2018.11.037","journal-title":"Gastroenterology"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2021.1877136","article-title":"Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals","volume":"15","author":"Nevola R","year":"2021","unstructured":"Nevola R, Rinaldi L, Zeni L, et al.. Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals. Expert Rev Gastroenterol Hepatol. 2021, 15:643-56. 10.1080\/17474124.2021.1877136","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.2174\/1381612822666151209153535","article-title":"Rheumatoid arthritis: notable biomarkers linking to chronic systemic conditions and cancer","volume":"22","author":"Olumuyiwa-Akeredolu OO","year":"2016","unstructured":"Olumuyiwa-Akeredolu OO, Pretorius E. Rheumatoid arthritis: notable biomarkers linking to chronic systemic conditions and cancer. Curr Pharm Des. 2016, 22:918-24. 10.2174\/1381612822666151209153535","journal-title":"Curr Pharm Des"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2217\/bem-2018-0001","article-title":"From neuroimunomodulation to bioelectronic treatment of rheumatoid arthritis","volume":"1","author":"Kanashiro A","year":"2018","unstructured":"Kanashiro A, Shimizu Bassi G, de Queir\u00f3z Cunha F, Ulloa L. From neuroimunomodulation to bioelectronic treatment of rheumatoid arthritis. Bioelectron Med (Lond). 2018, 1:151-65. 10.2217\/bem-2018-0001","journal-title":"Bioelectron Med (Lond)"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.709438","article-title":"Periodontal inflammation and systemic diseases: an overview","volume":"12","author":"Mart\u00ednez-Garc\u00eda M","year":"2021","unstructured":"Mart\u00ednez-Garc\u00eda M, Hern\u00e1ndez-Lemus E. Periodontal inflammation and systemic diseases: an overview. Front Physiol. 2021, 12:709438. 10.3389\/fphys.2021.709438","journal-title":"Front Physiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.prenap.2025.100145","article-title":"Natural remedies for hypertension: a systematic review","volume":"6","author":"Mizher HA","year":"2025","unstructured":"Mizher HA, Noor MI, Zaini S. Natural remedies for hypertension: a systematic review. Pharmacol Res Nat Prod. 2025, 6:100145. 10.1016\/j.prenap.2025.100145","journal-title":"Pharmacol Res Nat Prod"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3344\/kjp.23130","article-title":"Antimicrobial therapies for chronic pain (part 2): the prevention and treatment of chronic pain","volume":"36","author":"Wang EJ","year":"2023","unstructured":"Wang EJ, Dolomisiewicz E, Karri J, Tontisirin N, Cohen SP. Antimicrobial therapies for chronic pain (part 2): the prevention and treatment of chronic pain. Korean J Pain. 2023, 36:299-315. 10.3344\/kjp.23130","journal-title":"Korean J Pain"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15001","article-title":"Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome","volume":"48","author":"Ford AC","year":"2018","unstructured":"Ford AC, Harris LA, Lacy BE, Quigley EM, Moayyedi P. Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome. Aliment Pharmacol Ther. 2018, 48:1044-60. 10.1111\/apt.15001","journal-title":"Aliment Pharmacol Ther"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1913","article-title":"Management of chronic prostatitis\/chronic pelvic pain syndrome: a systematic review and network meta-analysis","volume":"305","author":"Anothaisintawee T","year":"2011","unstructured":"Anothaisintawee T, Attia J, Nickel JC, Thammakraisorn S, Numthavaj P, McEvoy M, Thakkinstian A. Management of chronic prostatitis\/chronic pelvic pain syndrome: a systematic review and network meta-analysis. JAMA. 2011, 305:78-86. 10.1001\/jama.2010.1913","journal-title":"JAMA"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0000000000000792","article-title":"Systemic metronidazole may not reduce posthemorrhoidectomy pain: a meta-analysis of randomized controlled trials","volume":"60","author":"Wanis KN","year":"2017","unstructured":"Wanis KN, Emmerton-Coughlin HM, Coughlin S, Foley N, Vinden C. Systemic metronidazole may not reduce posthemorrhoidectomy pain: a meta-analysis of randomized controlled trials. Dis Colon Rectum. 2017, 60:446-55. 10.1097\/DCR.0000000000000792","journal-title":"Dis Colon Rectum"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.spinee.2021.02.013","article-title":"Chronic low back pain, bacterial infection and treatment with antibiotics","volume":"21","author":"Gilligan CJ","year":"2021","unstructured":"Gilligan CJ, Cohen SP, Fischetti VA, Hirsch JA, Czaplewski LG. Chronic low back pain, bacterial infection and treatment with antibiotics. Spine J. 2021, 21:903-14. 10.1016\/j.spinee.2021.02.013","journal-title":"Spine J"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14108","article-title":"Systematic review: interventions for abdominal pain management in inflammatory bowel disease","volume":"46","author":"Norton C","year":"2017","unstructured":"Norton C, Czuber-Dochan W, Artom M, Sweeney L, Hart A. Systematic review: interventions for abdominal pain management in inflammatory bowel disease. Aliment Pharmacol Ther. 2017, 46:115-25. 10.1111\/apt.14108","journal-title":"Aliment Pharmacol Ther"},{"key":"ref37","article-title":"Dyspepsia and gastro-oesophageal reflux: a systematic review","author":"Swedish Council on Health Technology Assessment","year":"2007","unstructured":"Swedish Council on Health Technology Assessment. Dyspepsia and gastro-oesophageal reflux: a systematic review. Swedish Council on Health Technology Assessment (SBU), Stockholm; 2007."},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.21.2641","article-title":"Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials","volume":"293","author":"Andraws R","year":"2005","unstructured":"Andraws R, Berger JS, Brown DL. Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials. JAMA. 2005, 293:2641-7. 10.1001\/jama.293.21.2641","journal-title":"JAMA"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a034181","article-title":"Neural control of inflammation: bioelectronic medicine in treatment of chronic inflammatory disease","volume":"10","author":"Eberhardson M","year":"2020","unstructured":"Eberhardson M, Tarnawski L, Centa M, Olofsson PS. Neural control of inflammation: bioelectronic medicine in treatment of chronic inflammatory disease. Cold Spring Harb Perspect Med. 2020, 10:10.1101\/cshperspect.a034181","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3390\/ph16081089","article-title":"Pharmacological and electroceutical targeting of the cholinergic anti-inflammatory pathway in autoimmune diseases","volume":"16","author":"Zouali M","year":"2023","unstructured":"Zouali M. Pharmacological and electroceutical targeting of the cholinergic anti-inflammatory pathway in autoimmune diseases. Pharmaceuticals (Basel). 2023, 16:10.3390\/ph16081089","journal-title":"Pharmaceuticals (Basel)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/359167-chronic-inflammation-a-multidisciplinary-analysis-of-shared-pathways-in-autoimmune-infectious-and-degenerative-diseases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T12:49:32Z","timestamp":1745066972000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/359167-chronic-inflammation-a-multidisciplinary-analysis-of-shared-pathways-in-autoimmune-infectious-and-degenerative-diseases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,19]]},"references-count":40,"URL":"https:\/\/doi.org\/10.7759\/cureus.82579","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,19]]}}}